Knowles Expands RF Signal Chain Offering with New A-Series Attenuators Share Post Post navigation Previous PostABC Fine Wine & Spirits Surpasses $3 Million Raised for Pediatric Cancer ResearchNext Post New Phase 3b data show Lilly’s EBGLYSS (lebrikizumab-lbkz) delivered significant and rapid improvements in skin clearance, itch, pain, and patient satisfaction in people with moderate-to-severe hand and foot atopic dermatitis